3GC-93842-51585

4 vaccinations 16 coded responses 27 check-ins 16 free-text entries 1 call case

Sex: Female
Age at first dose: 05-11
ZIP prefix: 018 / MA
Registered: 2022-07-22

Relationship: Child or adolescent in my care
Guardian: PMG-22387-94270
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2393348 (opens in a new window)	high	9 / 11	—	1 of 9 VAERS symptoms	same dose (3)	MA matches	2022-07-22 / 2022-07-25 / 2022-07-27 received the same day as the last call	case 885643

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-03
Dose 1 — Pfizer-BioNTech
2022-01-07
Dose 2 — Pfizer-BioNTech
2022-07-22
Registered in v-safe
2022-07-22
Dose 3 — Pfizer-BioNTech
2022-07-22
Survey response — day 0, dose 3, dependent
MedDRA: Body temperature increased — Feeling: Good · Site: Pain, Swelling · Muscle or body aches

Free text: Temperature 99.9 F

MedDRA releases: 2024-11 · check-in free text available
2022-07-23
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-07-24
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-07-26
Survey response — days 1–6 daily, dose 3, dependent
MedDRA: Photopsia — Feeling: Good · Site: Swelling · Fever · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Flashing lights in outer corner of left eye.

MedDRA releases: 2024-11 · check-in free text available
2022-07-26
Report sent to call center — days 1–6 daily, dose 3, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-27
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · Site: Swelling · Fever · Fatigue or tiredness, Nausea

Adult check-in
2022-07-27
Call 1 — Could Not Reach Participant
2022-07-27
Call successful
Completed over the phone
2022-07-29
Survey response — day 7, dose 3, dependent
MedDRA: Skin warm — Feeling: Good · Site: Swelling · Fever

Free text: Arm is warm to touch.

MedDRA releases: 2024-11 · check-in free text available
2022-08-05
Survey response — day 14, dose 3, dependent
MedDRA: Body temperature increased — Feeling: Good

Free text: Consistent temp of 99.9 F in the morning which is not typical at all of her. Her evening temp are similar but does not go above 100.2 F.

MedDRA releases: 2024-11 · check-in free text available
2022-08-13
Survey response — day 21, dose 3, dependent
MedDRA: Body temperature increased — Feeling: Good

Free text: She continues to have a daily temperature of between 99.9 F in the morning to 100.2 in the evening. Her normal daily temperature before the Covid booster was between 96.7 - 97.9 F.

MedDRA releases: 2024-11 · check-in free text available
2022-08-19
Survey response — day 28, dose 3, dependent
MedDRA: Body temperature increased — Feeling: Good

Free text: It's not worsening but she continues to have a daily temperature of 99.3 -100.1 degrees F.

MedDRA releases: 2024-11 · check-in free text available
2022-08-27
Health check-in — day 35, dose 3, dependent
Feeling: Good

Adult check-in
2022-09-02
Health check-in — day 42, dose 3, dependent
Feeling: Good

Adult check-in
2022-10-23
Health check-in — 3 months, dose 3, dependent
Feeling: Good

Adult check-in
2022-11-04
Dose 4 — Pfizer-BioNTech
2022-11-04
Survey response — day 0, dose 4, dependent
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-05
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-06
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-07
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-08
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-09
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-10
Survey response — days 1–6 daily, dose 4, dependent
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-11
Survey response — day 7, dose 4, dependent
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-11-18
Health check-in — day 14, dose 4, dependent
Feeling: Good

Adult check-in
2022-11-25
Health check-in — day 21, dose 4, dependent
Feeling: Good

Adult check-in
2022-12-02
Health check-in — day 28, dose 4, dependent
Feeling: Good

Adult check-in
2022-12-10
Survey response — day 35, dose 4, dependent
MedDRA: Diarrhoea, Nausea — Feeling: Good · Be unable to work or attend school

Free text: Diarrhea and nausea

MedDRA releases: 2024-11 · check-in free text available
2022-12-18
Survey response — day 42, dose 4, dependent
MedDRA: Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activities

Free text: Sneezing, runny nose, sore throat.

MedDRA releases: 2024-11 · check-in free text available
2023-02-05
Health check-in — 3 months, dose 4, dependent
Feeling: Good

Adult check-in
2023-05-06
Health check-in — 6 months, dose 4, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-03	Pfizer-BioNTech	No
2	2022-01-07	Pfizer-BioNTech	No
3	2022-07-22	Pfizer-BioNTech	No
4	2022-11-04	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 12 — day 0, dose 3, dependent

2022-07-22

Systemic reaction (other): Temperature 99.9 F

Release 12 — days 1–6 daily, dose 3, dependent

2022-07-26

Systemic reaction (other): Flashing lights in outer corner of left eye.

Release 12 — day 7, dose 3, dependent

2022-07-29

Systemic reaction (other): Arm is warm to touch.

Release 12 — day 14, dose 3, dependent

2022-08-05

Symptoms: Consistent temp of 99.9 F in the morning which is not typical at all of her. Her evening temp are similar but does not go above 100.2 F.

Release 12 — day 21, dose 3, dependent

2022-08-13

Symptoms: She continues to have a daily temperature of between 99.9 F in the morning to 100.2 in the evening. Her normal daily temperature before the Covid booster was between 96.7 - 97.9 F.

Release 12 — day 28, dose 3, dependent

2022-08-19

Symptoms: It's not worsening but she continues to have a daily temperature of 99.3 -100.1 degrees F.

Release 12 — day 0, dose 4, dependent

2022-11-04

Systemic reaction (other): No

Release 12 — days 1–6 daily, dose 4, dependent

2022-11-05

Systemic reaction (other): No

2022-11-06

Systemic reaction (other): No

2022-11-07

Systemic reaction (other): No

2022-11-08

Systemic reaction (other): No

2022-11-09

Systemic reaction (other): No

2022-11-10

Systemic reaction (other): No

Release 12 — day 7, dose 4, dependent

2022-11-11

Systemic reaction (other): No

Release 12 — day 35, dose 4, dependent

2022-12-10

Symptoms: Diarrhea and nausea

Release 12 — day 42, dose 4, dependent

2022-12-18

Symptoms: Sneezing, runny nose, sore throat.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Body temperature increased	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Nausea	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Sneezing	·	·	✓
SRO	Body temperature increased	·	·	✓
SRO	No adverse event	·	·	✓
SRO	Photopsia	·	·	✓
SRO	Skin warm	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release